Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42251-42300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05718245
HEPA, PM2.5, and Cardiometabolic Health
NARecruiting
52 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06444126
The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
N/ARecruiting
650 participants
Started: Mar 15, 2023 · Completed: Sep 15, 2025
2 conditions1 sponsor1 location
NCT06429124
Time Restricted Eating in Alzheimer's Disease
NARecruiting
30 participants
Started: Mar 15, 2023 · Completed: Mar 14, 2026
1 condition4 sponsors2 locations
NCT05740943
Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
PHASE2Recruiting
48 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05734755
Dietary Programme and Exercise Training in Combination or Separately on Managing Sarcopenic Obesity in Older Adults
NARecruiting
380 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2026
1 condition1 sponsor1 location
NCT05846438
Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.
NARecruiting
100 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2025
2 conditions1 sponsor1 location
NCT06140914
Biological Mechanisms Behind Resynchronization Therapy in Heart Failure
N/ARecruiting
220 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05546879
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
PHASE1Recruiting
52 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2027
1 condition2 sponsors1 location
NCT05744934
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study
EARLY_PHASE1Recruiting
10 participants
Started: Mar 15, 2023 · Completed: Sep 10, 2027
1 condition1 sponsor1 location
NCT05908643
A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
PHASE1/PHASE2Recruiting
16 participants
Started: Mar 15, 2023 · Completed: Jun 30, 2032
1 condition5 sponsors2 locations
NCT05632744
Evaluation of CG-100 Intraluminal Bypass Device
NARecruiting
10 participants
Started: Mar 15, 2023 · Completed: Jun 15, 2024
1 condition1 sponsor1 location
NCT06314958
Stage II/III Colorectal Cancer Recurrence
N/ARecruiting
400 participants
Started: Mar 15, 2023 · Completed: Jun 18, 2026
5 conditions1 sponsor4 locations
NCT05772273
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
NARecruiting
43 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05782387
Mucolipidosis Type IV Natural History Study
N/ARecruiting
50 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05687357
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
PHASE2Recruiting
140 participants
Started: Mar 15, 2023 · Completed: Aug 31, 2027
2 conditions1 sponsor3 locations
NCT05435222
Evaluation of a Male-specific Psychotherapeutic Program for Major Depressive Disorders
NARecruiting
244 participants
Started: Mar 15, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05787561
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
PHASE2Recruiting
40 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT05660460
COPD at a Street Level
NARecruiting
511 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2029
1 condition2 sponsors1 location
NCT05301140
Vivistim Registry for Paired VNS Therapy (GRASP)
N/ARecruiting
1,000 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT06137755
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
PHASE1Recruiting
32 participants
Started: Mar 15, 2023 · Completed: Mar 21, 2025
2 conditions1 sponsor2 locations
NCT05763004
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Mar 15, 2023 · Completed: May 31, 2025
1 condition2 sponsors5 locations
NCT05709548
Use of Indocyanine Green in Acute Cholecystitis
PHASE4Recruiting
440 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05768841
Prevalence of Mental Health Issues in Endurance Athletes.
N/ARecruiting
500 participants
Started: Mar 15, 2023 · Completed: Sep 30, 2025
2 conditions4 sponsors1 location
NCT06219642
Mindfulness Intervention Using Virtual Reality in Older Adults With Symptoms of Anxiety and Depression in Ecuador
NARecruiting
90 participants
Started: Mar 15, 2023 · Completed: Aug 15, 2024
1 condition2 sponsors1 location
NCT05156736
Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
N/ARecruiting
2,000 participants
Started: Mar 15, 2023 · Completed: Nov 30, 2028
4 conditions2 sponsors1 location
NCT06320379
Zypan Functional Dyspepsia
NARecruiting
64 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05848609
Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer
NARecruiting
120 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor2 locations
NCT06318858
Daily and Weekly Iron Supplementation in Infants
NARecruiting
300 participants
Started: Mar 15, 2023 · Completed: Oct 14, 2024
4 conditions2 sponsors1 location
NCT05482893
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
PHASE1/PHASE2Recruiting
258 participants
Started: Mar 15, 2023 · Completed: Apr 30, 2028
3 conditions2 sponsors11 locations
NCT05310591
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
PHASE1/PHASE2Recruiting
26 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2027
2 conditions1 sponsor13 locations
NCT05212454
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
PHASE3Recruiting
400 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05423158
Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans
PHASE2Recruiting
150 participants
Started: Mar 15, 2023 · Completed: Feb 28, 2026
1 condition5 sponsors2 locations
NCT05789108
Deep Venous Thrombosis and Long Term Complications
NARecruiting
178 participants
Started: Mar 14, 2023 · Completed: Mar 9, 2026
1 condition1 sponsor1 location
NCT06419738
Efficacy of Combining Low Level Laser Therapy With Cognitive-behavioral Therapy on Myalgia in Temporomandibular Joint Disorders
NARecruiting
66 participants
Started: Mar 14, 2023 · Completed: Jan 4, 2025
1 condition1 sponsor1 location
NCT05830097
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
260 participants
Started: Mar 14, 2023 · Completed: Sep 30, 2025
5 conditions1 sponsor5 locations
NCT05763849
Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
NARecruiting
120 participants
Started: Mar 14, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT05795257
Pulmonary Immune Cell-microbiome Interactions in ARDS
N/ARecruiting
40 participants
Started: Mar 14, 2023 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT05740059
Restrictive Transfusion StratEgy Adjusted by SvO2 During Cardiac Surgery
NARecruiting
676 participants
Started: Mar 14, 2023 · Completed: Dec 12, 2025
2 conditions1 sponsor1 location
NCT05760612
Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab
PHASE3Recruiting
300 participants
Started: Mar 14, 2023 · Completed: Nov 1, 2028
5 conditions1 sponsor1 location
NCT06608589
CONSTELLATIONS Living Lab: Improving the Care Transitions of Older Adults Living with Neurocognitive Disorders
NARecruiting
700 participants
Started: Mar 14, 2023 · Completed: Apr 30, 2026
3 conditions3 sponsors1 location
NCT06311110
Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD
N/ARecruiting
84 participants
Started: Mar 14, 2023 · Completed: Jun 1, 2025
3 conditions1 sponsor2 locations
NCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
N/ARecruiting
500 participants
Started: Mar 14, 2023 · Completed: Sep 14, 2028
9 conditions1 sponsor1 location
NCT05799105
OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
PHASE4Recruiting
122 participants
Started: Mar 14, 2023 · Completed: Dec 23, 2025
1 condition1 sponsor1 location
NCT05819697
Reducing Patient Memory Recall in the Burning Mouth Patient Population
N/ARecruiting
50 participants
Started: Mar 14, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05755269
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
N/ARecruiting
50 participants
Started: Mar 14, 2023 · Completed: Jan 15, 2033
4 conditions1 sponsor1 location
NCT05736302
Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
N/ARecruiting
125 participants
Started: Mar 14, 2023 · Completed: Dec 31, 2026
2 conditions4 sponsors1 location
NCT05841355
MADRE (Mammograms Available Due to Research and Education)
NARecruiting
600 participants
Started: Mar 14, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor2 locations
NCT05520866
PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery
NARecruiting
132 participants
Started: Mar 14, 2023 · Completed: Apr 15, 2026
1 condition2 sponsors3 locations
NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
270 participants
Started: Mar 14, 2023 · Completed: Mar 31, 2029
9 conditions1 sponsor10 locations
NCT05719194
Effect of a Personalized Weaning Strategy on Weaning Success
NARecruiting
750 participants
Started: Mar 14, 2023 · Completed: Mar 23, 2026
3 conditions1 sponsor9 locations